Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
01-2003 | 10-2002 | 07-2002 | 04-2002 | 01-2002 | |
Sales | 91 | 39 | 1,254 | 2,617 | 1,277 |
Cost of Goods | 62 | 109 | 508 | 828 | 426 |
Gross Profit | 29 | -70 | 746 | 1,789 | 851 |
Operating Expenses | 898 | 1,256 | 4,289 | 1,729 | 1,222 |
Operating Income | -806 | -1,217 | -3,035 | 888 | 56 |
Other Income | 2 | 3 | 6 | 10 | 5 |
Pre-tax Income | -805 | -1,214 | -3,029 | 898 | 60 |
Net Income Continuous | -805 | -1,214 | -3,029 | 898 | 60 |
Net Income | $-805 | $-1,214 | $-3,029 | $898 | $60 |
EPS Basic Total Ops | -0.25 | -0.50 | -1.00 | 0.25 | 0.00 |
EPS Basic Continuous Ops | -0.28 | -0.45 | -1.11 | 0.33 | 0.02 |
EPS Diluted Total Ops | -0.25 | -0.50 | -1.00 | 0.25 | 0.00 |
EPS Diluted Continuous Ops | -0.28 | -0.45 | -1.11 | 0.33 | 0.02 |
EBITDA(a) | $-796 | $-1,202 | $-3,013 | $913 | $80 |